STARSET_MirrorPharmaceutical Companies Prepare to Profit from the Coronavirus
As the new coronavirus spreads illness, death, and catastrophe around the world, virtually no economic sector has been spared from harm. Yet amid the mayhem from the global pandemic, one industry is not only surviving, it is profiting handsomely.
随着这种新型冠状病毒在世界各地传播疾病、死亡和灾难，几乎没有哪个经济部门能幸免；然而在全球大流行的混乱中，有一个行业不仅存活了下来，而且还获得了丰厚的利润。
“Pharmaceutical companies view Covid-19 as a once-in-a-lifetime business opportunity,” said Gerald Posner, author of “Pharma: Greed, Lies, and the Poisoning of America.” The world needs pharmaceutical products, of course. For the new coronavirus outbreak, in particular, we need treatments and vaccines and, in the U.S., tests. Dozens of companies are now vying to make them.
《制药:贪婪、谎言和毒害美国》一书的作者杰拉尔德•波斯纳表示：“制药公司将covid19视为千载难逢的商机。”当然世界需要医药产品，特别是对于新的冠状病毒爆发，我们需要治疗和疫苗和测试，几十家公司现在都在争相生产。
“They’re all in that race,” said Posner, who described the potential payoffs for winning the race as huge. The global crisis “will potentially be a blockbuster for the industry in terms of sales and profits,” he said, adding that “the worse the pandemic gets, the higher their eventual profit.”
波斯纳说:“他们都在这场比赛当中了。”他认为赢得这场比赛的潜在回报是巨大的；他说：“这场全球危机中，在销售额和利润方面可能会给这个行业带来巨大冲击”，并补充说到：“疫情越严重，最终的利润就越高。”
Read more at The Intercept
翻译：SGCS翻译组
